ClinicalTrials.Veeva

Menu

Effectiveness of Interactive Exergame in Older Adults With Sarcopenia

T

Taipei Medical University

Status

Unknown

Conditions

Sarcopenia

Treatments

Other: Interactive Exergame

Study type

Interventional

Funder types

Other

Identifiers

NCT04770558
N202012029

Details and patient eligibility

About

Sarcopenia has been defined as an age related, involuntary loss of skeletal muscle mass and strength. The prevalence of sarcopenia is about 10% globally, and risk factors of sarcopenia includes age, lower physical activity, and malnutrition. Sarcopenia can lead to many adverse health outcomes, particularly in physical and cognitive functions. Most of previous studies have reported that interactive exergame can improve cognitive and physical functions in older population but none of studies use of interactive exergame on older adults with sarcopenia. Therefore, the aim of study will investigate the effects of interactive exergame on older adults with sarcopenia.

Full description

A total of 60 older participants will be randomly assigned to the experimental and control groups. Participants in the experimental group will receive 40 minutes per session, 2 times a week for 12 weeks interactive exergame while those in the control group will maintain their regular activity. All participants will be assessed their physical and cognitive function, sarcopenia index and other health related outcome measurements before and after intervention program.

Enrollment

60 estimated patients

Sex

All

Ages

65 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. 65-99 years old
  2. able to walk 6 meters without assistance devices
  3. older adults with possible sarcopenia, sarcopenia or severe sarcopenia

Exclusion criteria

  1. people with hemodialysis
  2. people with built-in electronic medical equipment
  3. people with central nervous system disease such as stroke or Parkinson's disease
  4. score in ascertain dementia 8 more than 2
  5. people with mental illness

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Exergame group
Experimental group
Description:
The exergame group will receive exergame training for 12 weeks, 2 times a week and 60 min per session.
Treatment:
Other: Interactive Exergame
Control group
No Intervention group
Description:
The control group will not receive any intervention and maintain their lifestyle for 12 weeks.

Trial contacts and locations

1

Loading...

Central trial contact

Shu-Chun Lee, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems